Trieu Vuong

Insider Reports History

Entity
Individual
Location
4003 Jim Bowie Road, Agoura Hills, CA
Signature
/s/ Trieu, Vuong
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Trieu Vuong:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Oncotelic Therapeutics, Inc. CHAIRMAN AND CEO, Director, 10%+ Owner Common Stock 92.5M $1.85M $0.02 Aug 23, 2024 Direct
Oncotelic Therapeutics, Inc. CHAIRMAN AND CEO, Director, 10%+ Owner Common Stock 16.8M $336K $0.02 Aug 23, 2024 By Autotelic, Inc.
Oncotelic Therapeutics, Inc. CHAIRMAN AND CEO, Director, 10%+ Owner Common Stock 6.87M $137K $0.02 Aug 23, 2024 By Spouse

Insider Reports Filed by Trieu Vuong

Symbol Company Period Transactions Value $ Form Type Date Filed Role
OTLC Oncotelic Therapeutics, Inc. Aug 23, 2024 1 $10K 4 Aug 27, 2024 CHAIRMAN AND CEO, Director, 10%+ Owner
OTLC Oncotelic Therapeutics, Inc. Jun 28, 2023 2 $10.9K 4 Jun 30, 2023 CHAIRMAN AND CEO, Director, 10%+ Owner
OTLC Oncotelic Therapeutics, Inc. Jun 16, 2023 1 $2.6K 4 Jun 20, 2023 CHAIRMAN AND CEO, Director, 10%+ Owner
OTLC Oncotelic Therapeutics, Inc. Jun 14, 2023 1 $13K 4 Jun 16, 2023 CHAIRMAN AND CEO, Director, 10%+ Owner
OTLC Oncotelic Therapeutics, Inc. May 26, 2023 1 $4.33K 4 May 31, 2023 CHAIRMAN AND CEO, Director, 10%+ Owner
OTLC Oncotelic Therapeutics, Inc. May 2, 2023 1 $4.5K 4 May 2, 2023 CHAIRMAN AND CEO, Director, 10%+ Owner
OTLC Oncotelic Therapeutics, Inc. Dec 6, 2022 1 $6K 4 Dec 7, 2022 CHAIRMAN AND CEO, Director, 10%+ Owner
OTLC Oncotelic Therapeutics, Inc. Nov 22, 2022 1 $5.6K 4 Nov 25, 2022 CHAIRMAN AND CEO, Director, 10%+ Owner
OTLC Oncotelic Therapeutics, Inc. Sep 26, 2022 1 $1.36K 4 Sep 28, 2022 CHAIRMAN AND CEO, Director, 10%+ Owner
OTLC Oncotelic Therapeutics, Inc. Aug 25, 2022 1 $6.56K 4 Aug 29, 2022 CHAIRMAN AND CEO, Director, 10%+ Owner
OTLC Oncotelic Therapeutics, Inc. Sep 3, 2021 1 $0 4 Sep 8, 2021 Chief Executive Officer, Director
OTLC Oncotelic Therapeutics, Inc. Mar 31, 2021 8 $0 4 Jul 16, 2021 CHAIRMAN AND CEO, Director, 10%+ Owner